Details

Vloga proteomike v diagnostiki klinično pomembnega raka prostate - preliminarni rezultati študije
ID Ditz, Iztok (Author), ID Smrkolj, Tomaž (Author), ID Osredkar, Joško (Author), ID Šelb, Julij (Author)

.pdfPDF - Presentation file, Download (281,33 KB)
MD5: F8874D6ACA72ADF663F5985F4314D1E0
URLURL - Source URL, Visit https://www.szd.si/55-kirurski-dnevi-2025/ This link opens in a new window

Abstract
Rak prostate (CaP) je najpogostejši rak pri moških v Sloveniji. Obstoječ diagnostični algoritem s PSA (prostata specifičen antigen) in BX (biopsija prostate) ima številne omejitve, predvsem v sivi coni vrednosti PSA (2–10 ng/mL). Cilj sodobne diagnostike je izboljšanje specifičnosti in občutljivosti testov ter prepoznavanje klinično pomembnega CaP G 7 (Gleason ≥ 7). Proteomika kot veda o proteinih omogoča identifikacijo tumorskih označevalcev, ki lahko izboljšajo selekcijo bolnikov za biopsijo. V študiji smo analizirali 83 bolnikov, ki so opravili MR (magnentna resonanca)-ciljano fuzijsko TRUZ (transrektalni ultrazvok) BX prostate, ob tem pa so jim bili odvzeti vzorci za analizo tumorskih označevalcev s testom Olink Target 96 Oncology II. Najdenih je bilo več tumorskih označevalcev s statistično značilnimi razlikami med skupinami: ITGAV, TRAIL, FGF-BP1 in MSLN, med katerimi so prvi trije pokazali najvišjo uporabnost za diagnostiko klinično pomembnega raka prostate.

Language:Slovenian
Keywords:rak prostate, proteomika, diagnostika
Work type:Article
Typology:1.08 - Published Scientific Conference Contribution
Organization:MF - Faculty of Medicine
Publication status:Published
Publication version:Version of Record
Year:2025
Number of pages:Str. 155-161
PID:20.500.12556/RUL-191055 This link opens in a new window
UDC:616.6
COBISS.SI-ID:259930883 This link opens in a new window
Copyright:
Objavljeni članek je v repozitorij shranjen na podlagi dovoljenja uredništva nadrejene revije. (Datum opombe: 11.11.2026)
Publication date in RUL:11.11.2026
Views:20
Downloads:6
Metadata:XML DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a monograph

Title:9. slovenski urološki kongres z mednarodno udeležbo, s simpozijem urološke zdravstvene nege Slovenije in z evropsko urološko šolo ESU : zbornik izvlečkov
Editors:Simon Hawlina
Place of publishing:Slovenska Bistrica
Publisher:VI vis
Year:2025
ISBN:978-961-96357-3-5
COBISS.SI-ID:251666179 This link opens in a new window

Secondary language

Language:English
Title:The role of proteomics in the diagnosis of clinically significant prostate cancer - preliminary results of the study
Abstract:
Prostate cancer (CaP) is the most common cancer among men in Slovenia. However, the current diagnostic algorithm using PSA (prostate specific antigen) and BX (prostate biopsy) has notable limitations, especially in the gray zone of PSA values (2–10 ng/mL). The aim of modern diagnostics is to improve test specificity and sensitivity, and to better identify clinically significant CaP G 7 (Gleason ≥ 7). Proteomics, the study of proteins, enables biomarker identification to improve patient selection for BX. In this study, we analyzed 83 patients undergoing MRI (magnetic resonance imaging)-targeted fusion TRUS (transrectal ultrasound) prostate BX and biomarker testing via the Olink Target 96 Oncology II panel. Several biomarkers showed statistically significant differences between histopathological groups: ITGAV, TRAIL, FGF-BP1 and MSLN, with the first three being the most promising for detecting clinically significant prostate cancer.


Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back